Yahoo Web Search

Search results

    • Kura Oncology Gets Breakthrough Designation For Leukemia Therapy

      Morningstar· 19 hours ago

      By Ben Glickman Kura Oncology said Monday it received a breakthrough therapy designation from regulators for ziftomenib, its potential treatment for a form of leukemia. The San Diego-based biopharmaceutical company said the U.S. Food and